D-(threo)-1-aryl-2-disubstitutedacylamido-3-fluoro-1-propanol compounds compounds and analogues thereof (“Fenicol Compounds”), compositions comprising an effective amount of a Fenicol Compound, and methods for treating or preventing a bacterial infection in an animal comprising administering to an animal in need thereof an effective amount of a Fenicol Compound are disclosed.
Fenicol compounds and methods synthesizing 2-trifluoroacetamido-3-substituted propiophenone compounds
申请人:Murthy V.S.N Yerramilli
公开号:US20070197823A1
公开(公告)日:2007-08-23
Methods of preparing compounds of formula (I):
wherein Y, Y
1
, and R
2
are defined herein; methods of making D-(threo)-1-aryl-2-acylamido-1-propanol compounds, D-(threo)-1-aryl-2-acylamido-3-fluoro-1-propanol compounds, and D-(threo)-1-aryl-2-acylamido-3-hydroxy-1-propanol compounds (collectively, “fenicol compounds”) from the compound of formula (I); and new fenicol compounds, which can be made using the method.
[EN] PHARMACEUTICAL COMPOSITIONS WITH IMPROVED DISSOLUTION<br/>[FR] COMPOSITIONS PHARMACEUTIQUES A DISSOLUTION AMELIOREE
申请人:TRANSFORM PHARMACEUTICALS INC
公开号:WO2004000284A1
公开(公告)日:2003-12-31
The invention relates to methods of screening mixtures containing a pharmaceutical compound an excipient to identify properties of the pharmaceutical compound/excipient combination that retard solid-state nucleation. The invention further relates to increasing the solubility, dissolution and bioavailability of a drug with low solubility in gastric fluids conditions by combining the drug with a recrystallization/precipitation retardant and an optional enhancer.
Pharmaceutical compositions with improved dissolution
申请人:Tawa Mark
公开号:US20060134198A1
公开(公告)日:2006-06-22
The invention relates to methods of screening mixtures containing a pharmaceutical compound and an excipient to identify properties of the pharmaceutical compound/excipient combination that retard solid-state nucleation. The invention further relates to increasing the solubility, dissolution and bioavailability of a drug with low solubility in gastric fluids conditions by combining the drug with a precipitation retardant and an optional enhancer.
Fenicol compounds and methods of synthesizing 2-trifluoracetamido-3-substituted propiophenone compounds
申请人:IDEXX LABORATORIES, INC.
公开号:EP1953138A2
公开(公告)日:2008-08-06
Methods of preparing compounds of formula (I):
wherein Y, Y1, and R2 are defined herein; methods of making D-(threo)-1-aryl-2- acylamido-1-propanol compounds, D-(threo)-1-aryl-2- acylamido-3-fluoro-1-propanol compounds, and D-(threo)-1-aryl-2- acylamido-3-hydroxy-1-propanol compounds (collectively, "fenicol compounds") from the compound of formula (I); and new fenicol compounds, which can be made using the method.